SLSBio(Specialty Lab Solution Bio) operates in the Leasing sector.
Legal name: SLSBio(Specialty Lab Solution Bio) Co., Ltd
In fiscal year 2025, SLSBio(Specialty Lab Solution Bio) (246250) reported revenue of 4.0 billion KRW, down 52.4% from 8.4 billion KRW a year earlier.
Operating profit was -4.1 billion KRW and net income was -4.9 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 30.2 billion KRW, with a P/B of 3.96.
These figures can be verified in the DART filing (receipt no. 20260629000531).
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |